Search Results Search Sort by RelevanceMost Recent Policy Forum Feb 2017 What Is the Relevance of Procedural Fairness to Making Determinations about Medical Evidence? Govind Persad, JD, PhD Procedures for weighing factual evidence could help avoid the epistemic injustice of discounting or ignoring the voices of clinical research subjects. AMA J Ethics. 2017;19(2):183-191. doi: 10.1001/journalofethics.2017.19.2.pfor1-1702. Policy Forum Feb 2017 Seeking Legitimacy for DSM-5: The Bereavement Exception as an Example of Failed Process James E. Sabin, MD and Norman Daniels, PhD The DSM-5 Task Force’s handling of the ethical controversy over the bereavement exclusion demonstrates the need for more inclusive deliberative processes. AMA J Ethics. 2017;19(2):192-198. doi: 10.1001/journalofethics.2017.19.2.pfor2-1702. Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022;24(5):E361-367. doi: 10.1001/amajethics.2022.361. Case and Commentary May 2022 ¿Cómo deberían responder los médicos al interés de los pacientes sobre suplementos dietético para tratar enfermedades crónicas graves? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES AMA J Ethics. 2022;E361-367. doi: 10.1001/amajethics.2022.361. Case and Commentary Dec 2022 How Should Clinicians Ally With Patients Whose Health Is Unlikely to Be Improved by Even Numerous Clinical Encounters? Adam T. Perzynski, PhD and Kurt C. Stange, MD, PhD Patients experiencing homelessness and mental illness face conditions and circumstances that deserve focused ethical and clinical attention. AMA J Ethics. 2022;24(12):E1112-1120. doi: 10.1001/amajethics.2022.1112. Case and Commentary Jun 2011 Herbal Supplements as Placebos Valerie Jones, MD Even if a placebo is safe, it should not be employed as a way of mollifying patients or glossing over underlying causes of illness. Virtual Mentor. 2011;13(6):354-358. doi: 10.1001/virtualmentor.2011.13.6.ccas3-1106.
Policy Forum Feb 2017 What Is the Relevance of Procedural Fairness to Making Determinations about Medical Evidence? Govind Persad, JD, PhD Procedures for weighing factual evidence could help avoid the epistemic injustice of discounting or ignoring the voices of clinical research subjects. AMA J Ethics. 2017;19(2):183-191. doi: 10.1001/journalofethics.2017.19.2.pfor1-1702.
Policy Forum Feb 2017 Seeking Legitimacy for DSM-5: The Bereavement Exception as an Example of Failed Process James E. Sabin, MD and Norman Daniels, PhD The DSM-5 Task Force’s handling of the ethical controversy over the bereavement exclusion demonstrates the need for more inclusive deliberative processes. AMA J Ethics. 2017;19(2):192-198. doi: 10.1001/journalofethics.2017.19.2.pfor2-1702.
Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022;24(5):E361-367. doi: 10.1001/amajethics.2022.361.
Case and Commentary May 2022 ¿Cómo deberían responder los médicos al interés de los pacientes sobre suplementos dietético para tratar enfermedades crónicas graves? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES AMA J Ethics. 2022;E361-367. doi: 10.1001/amajethics.2022.361.
Case and Commentary Dec 2022 How Should Clinicians Ally With Patients Whose Health Is Unlikely to Be Improved by Even Numerous Clinical Encounters? Adam T. Perzynski, PhD and Kurt C. Stange, MD, PhD Patients experiencing homelessness and mental illness face conditions and circumstances that deserve focused ethical and clinical attention. AMA J Ethics. 2022;24(12):E1112-1120. doi: 10.1001/amajethics.2022.1112.
Case and Commentary Jun 2011 Herbal Supplements as Placebos Valerie Jones, MD Even if a placebo is safe, it should not be employed as a way of mollifying patients or glossing over underlying causes of illness. Virtual Mentor. 2011;13(6):354-358. doi: 10.1001/virtualmentor.2011.13.6.ccas3-1106.